Patrick Burnett
3PUBLICATIONS
24CO-AUTHORS

Get your video featured.

Get your video featured.
Publications (3)
Sort by Publication Date:
|Nov 01, 2025
Long-Term Safety and Efficacy of Roflumilast Foam 0.3% in Patients with Seborrheic Dermatitis: A Phase II, Open-Label Trial of up to 52 Weeks.Andrew F Alexis, Michael Bukhalo, Fran E Cook-Bolden
Pageof 1
Frequent Collaborators
2 joint publications
Zoe D Draelos
2 joint publications
Janet DuBois
2 joint publications
Edward Lain
2 joint publications
Matthew Zirwas
2 joint publications
David R Berk
2 joint publications
Kim A Papp
2 joint publications
Seth B Forman
2 joint publications
Adelaide A Hebert
2 joint publications
Melinda J Gooderham
1 joint publications
Andrew F Alexis